Skip to main content
. Author manuscript; available in PMC: 2020 Apr 1.
Published in final edited form as: Lancet HIV. 2019 Feb 27;6(4):e240–e249. doi: 10.1016/S2352-3018(18)30360-6

Table 1.

Baseline characteristics of study sample, NA-ACCORD, 1996–2014.

Characteristic All (N=102,131) N (%) NHL cases (N=712) N (%)
Sex
 Male 86,479 (84·7) 640 (89·9)
 Female 15,652 (15·3) 72 (10·1)
Race/ethnicity
 Black 41,123 (40·3) 236 (33·2)
 White 44,437 (43·5) 385 (54·1)
 Hispanic 6,888 (6·7) 41 (5·8)
 Other 4,070 (4·0) 26 (3·7)
 Unknown imputed 5,613 (5·5) 24 (3·4)
Age, years
 18–29 13,069 (12·8) 54 (7·6)
 30–39 30,711 (30·1) 199 (28·0)
 40–49 35,682 (34·9) 283 (39·8)
 ≥50 22,669 (22·2) 176 (24·7)
Calendar period
 1996–1999 32,230 (31·6) 400 (56·2)
 2000–2003 25,794 (25·3) 174 (24·4)
 2004–2007 19,710 (19·3) 90 (12·6)
 2008–2011 18,194 (17·8) 44 (6·2)
 2012–2014 6,203 (6·1) 4 (0·6)
Combination ART naive
 No 33,792 (33·1) 180 (25·3)
 Yes 68,339 (66·9) 532 (74·7)
CD4 count, cells per μL
 <50 11,111 (10·9) 106 (14·9)
 50–<100 6,773 (6·6) 80 (11·2)
 100–<200 13,446 (13·2) 143 (20·1)
 200–<350 22,109 (21·6) 152 (21·3)
 350–<500 19,996 (19·6) 115 (16·2)
 ≥500 28,696 (28·1) 116 (16·3)
HIV RNA level, copies per mL
 ≤500 30,869 (30·2) 117 (16·4)
 >500–<10,000 20,653 (20·2) 128 (18·0)
 10,000–<100,000 30,194 (29·6) 259 (36·4)
 ≥100,000 20,415 (20·0) 208 (29·2)
HIV risk group
 Injection drug use 12,630 (12·4) 87 (12·2)
 Men who have sex with men 32,461 (31·8) 206 (28·9)
 Heterosexual 16,023 (15·7) 74 (10·4)
 Other 2,058 (2·0) 16 (2·3)
 Unknown imputeda 5,582 (5·5) 35 (4·9)
 Unknown not imputeda 33,374 (32·7) 294 (41·3)
Smoking status
 Ever 54,670 (53·5) 435 (61·1)
 Never 19,355 (19·0) 121 (17·0)
 Unknown imputeda 15,610 (15·3) 60 (8·4)
 Unknown not imputeda 12,496 (12·2) 96 (13·5)

ART=antiretroviral therapy. NHL=non-Hodgkin lymphoma.

a

We imputed HIV risk group and smoking status for persons with unknown values, except for cohorts with a high proportion of unknowns, or, for smoking, with all the knowns being smokers.